- Home
- / Samil Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Samil Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩15.8 K
2024-10-29
Market Capitalization
₩320.9 B
2024-10-29
Revenue
₩219.7 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 94.6B | 121.1B | 123.0B | 134.2B | 179.7B | 196.3B | 219.7B |
| Cost of goods sold | 49.9B | 63.5B | 69.2B | 74.9B | 100.5B | 118.9B | 138.8B |
| Gross profit | 44.8B | 58.0B | 54.2B | 59.7B | 79.5B | 77.7B | 81.3B |
| Gross profit margin, % | 47.4% | 47.9% | 44.1% | 44.5% | 44.3% | 39.6% | 37.0% |
| Operating expense total | 46.8B | 48.7B | 42.6B | 54.3B | 70.2B | 66.1B | 77.4B |
| Depreciation and amortization | 3.7B | 4.0B | 4.6B | 4.7B | 5.0B | 4.9B | 3.4B |
| EBITDA | (1.9B) | 9.3B | 11.6B | 5.4B | 9.5B | 11.6B | 3.9B |
| EBITDA margin, % | -2.0% | 7.7% | 9.4% | 4.0% | 5.3% | 5.9% | 1.8% |
| EBIT | (5.8B) | 5.1B | 6.8B | 517.6M | 4.3B | 5.7B | (796.4M) |
| EBIT margin, % | -6.1% | 4.2% | 5.5% | 0.4% | 2.4% | 2.9% | -0.4% |
| Interest income | 82.0M | 202.9M | 160.2M | 126.9M | 68.1M | 33.4M | 61.1M |
| Interest expense | 2.4B | 3.9B | 5.5B | 6.2B | 4.3B | 3.5B | 5.1B |
| Pre tax profit | (8.1B) | 1.5B | 1.2B | (4.8B) | 1.1B | 1.4B | (3.6B) |
| Income tax expense | 427.6M | 669.3M | (142.5M) | 585.3M | 1.1B | (239.8M) | 2.0B |
| Net Income | (8.6B) | 786.3M | 1.3B | (5.3B) | (28.3M) | 1.7B | (5.6B) |